definiens: means all Patents in Schedule 1.1 . 5, item 1 ( NKG2A Autoimmune / INNA-041228 ), Schedule 1.1.5 item 7 ( Ant i - KIR / ADCC / INNA-030724 ), and Schedule 1.1.16, item 2.5 ( LDGL CIP / INNA-051014 ), and any continuations or divisionals thereof or patents issuing from any suc h patent applications and all patent applications claiming priority to * * *, any patent a pplication directed to an invention made before December 31, 2009 relating to agents th at modulate NKp46 and/or LLT-1 and that is based on a new original application not listed in the update to the Schedules of May 22, 2008, and any continuations or divisiona ls thereof or patents issuing from any such patent applications )